Midtrimester N-terminal proatrial natriuretic peptide, free beta hCG, and alpha-fetoprotein in predicting preeclampsia

Obstetrics and Gynecology

Volumn 91, Issue 6, 1998, Pages 940-944

  Pouta, Anneli M ^a   Hartikainen, Anna Liisa ^a   Vuolteenaho, Olli J ^a   Ruokonen, Aimo O ^a   Laatikainen, Timo J ^b  

^a UNIVERSITY OF OULU   (Finland)

^b Helsinki City Maternity Hospital   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; ATRIAL NATRIURETIC FACTOR; CHORIONIC GONADOTROPIN BETA SUBUNIT; HORMONE PRECURSOR; PROATRIAL NATRIURETIC FACTOR; UNCLASSIFIED DRUG;

ADULT; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MATERNAL SERUM; PREECLAMPSIA; PRIORITY JOURNAL; RISK FACTOR;

ADULT; ALPHA-FETOPROTEINS; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; COHORT STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MASS SCREENING; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, SECOND; PROTEIN PRECURSORS; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 0031861934     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(98)00112-4     Document Type: Article

References (23)

1. Castro L.C., Hobel C.J., Cornbein J. Plasma levels of atrial natriuretic peptide in normal and hypertensive pregnancies A meta-analysis . Am J Obstet Gynecol. 171:1994;1642-1651.
2. Malee M.P., Malee K.M., Azuma S.D., Taylor R.N., Roberts J.M. Increases in plasma atrial natriuretic peptide concentration antedate clinical evidence of preeclampsia. J Clin Endocrinol Metab. 74:1992;1095-1100.
3. Pouta A.M., Vuolteenaho O.J., Laatikainen T.J. An increase of the plasma N-terminal peptide of proatrial natriuretic peptide in preeclampsia. Obstet Gynecol. 89:1997;747-753.
4. Walters B.N.J., Lao T., Smith V., De Swiet M. Alpha-fetoprotein elevation and proteinuric pre-eclampsia. Br J Obstet Gynaecol. 92:1985;341-344.
5. Brazerol W.F., Grover S., Donnenfeld A.E. Unexplained elevated maternal serum gamma-fetoprotein levels and perinatal outcome in an urban clinic population. Am J Obstet Gynecol. 171:1994;1030-1035.
6. Waller D.K., Lustig L.S., Cunningham G.C., Feuchtbaum L.B., Hook E.B. The association between maternal serum alpha-fetoprotein and preterm birth, small for gestational age infants, preeclampsia, and placental complications. Obstet Gynecol. 88:1996;816-822.
7. Gonen R., Perez R., David M., Dar H., Merksamer R., Sharf M. The association between unexplained second-trimester maternal serum hCG elevation and pregnancy complications. Obstet Gynecol. 80:1992;83-86.
8. Sorensen T.K., Williams M.A., Zingheim R.W., Clement S.J., Hickok D.E. Elevated second-trimester human chorionic gonadotropin and subsequent pregnancy-induced hypertension. Am J Obstet Gynecol. 169:1993;834-838.
9. Muller F., Savey L., Le Fiblec B., Bussières L., Ndayizamba G., Colau J.C., et al. Maternal serum human chorionic gonadotropin level at fifteen weeks is a predictor for preeclampsia. Am J Obstet Gynecol. 175:1996;37-40.
10. Phillips O.P., Simpson J.L., Morgan C.D., Andersen R.N., Shulman L.P., Meyers C.M., et al. Unexplained elevated maternal serum alpha-fetoprotein is not predictive of adverse perinatal outcome in an indigent urban population. Am J Obstet Gynecol. 166:1992;978-982.
11. Morssink L.P., Heringa M.P., Beekhuis J.R., De Wolf B.T.H.M., Mantingh A. The association between hypertensive disorders of pregnancy and abnormal second-trimester maternal serum levels of hCG and alpha-fetoprotein. Obstet Gynecol. 89:1997;666-670.
12. Spencer K., Coombes E.J., Mallard A.S., Ward A.M. Free beta human choriogonadotropin in Down's syndrome screening A multicentre study of its role compared with other biochemical markers . Ann Clin Biochem. 29:1992;506-518.
13. Vuolteenaho O., Koistinen P., Martikkala V., Takala T., Leppäluoto J. Effect of physical exercise in hypobaric conditions on atrial natriuretic peptide secretion. Am J Physiol. 263:1992;R647-R652.
14. Groenendijk R., Trimbos J.B., Wallenburg H.C. Hemodynamic measurements in preeclampsia Preliminary observations . Am J Obstet Gynecol. 150:1984;232-236.
15. Hankins G.D.V., Wendel G.D. Jr, Cunningham F.G., Leveno K.J. Longitudinal evaluation of hemodynamic changes in eclampsia. Am J Obstet Gynecol. 150:1984;506-512.
16. Phelan J.P., Yurth D.A. Severe preeclampsia. I. Peripartum hemodynamic observations. Am J Obstet Gynecol. 144:1982;17-22.
17. Visser W., Wallenburg H.C.S. Central hemodynamic observations in untreated preeclamptic patients. Hypertension. 17:1991;1072-1077.
18. Pouta A.M., Räsänen J.P., Airaksinen K.E.J., Vuolteenaho O.J., Laatikainen T.J. Changes in maternal heart dimensions and plasma atrial natriuretic peptide levels in the early puerperium of normal and pre-eclamptic pregnancies. Br J Obstet Gynaecol. 103:1996;988-992.
19. Stasch J.-P., Hirth-Dietrich C., Kazda S., Neuser D. Endothelin stimulates release of atrial natriuretic peptides in vitro and in vivo. Life Sci. 45:1989;869-875.
20. Mäntymaa P., Leppäluoto J., Ruskoaho H. Endothelin stimulates basal and stretch-induced atrial natriuretic peptide secretion from perfused rat heart. Endocrinology. 126:1990;587-595.
21. Lerman A., Gibbons R.J., Rodeheffer R.J., Bailey K.R., McKinley L.J., Heublein D.M., et al. Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction. Lancet. 341:1993;1105-1109.
22. Buckley M.G., Sagnella G.A., Markandu N.D., Singer D.R.J., MacGregor G.A. Immunoreactive N-terminal pro-atrial natriuretic peptide in human plasma Plasma levels and comparisons with α-human atrial natriuretic peptide in normal subjects, patients with essential hypertension, cardiac transplant and chronic renal failure . Clin Sci. 77:1989;573-579.
23. Moutquin J.M., Rainville C., Giroux L., Raynauld P., Amyot G., Bilodeau R., et al. A prospective study of blood pressure in pregnancy Prediction of preeclampsia . Am J Obstet Gynecol. 151:1985;191-196.